Home > Compound List > Compound details
14838-15-4 molecular structure
click picture or here to close

(1S,2R)-2-amino-1-phenylpropan-1-ol

ChemBase ID: 280
Molecular Formular: C9H13NO
Molecular Mass: 151.20562
Monoisotopic Mass: 151.09971404
SMILES and InChIs

SMILES:
O[C@H]([C@H](N)C)c1ccccc1
Canonical SMILES:
O[C@@H](c1ccccc1)[C@H](N)C
InChI:
InChI=1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3/t7-,9-/m1/s1
InChIKey:
DLNKOYKMWOXYQA-VXNVDRBHSA-N

Cite this record

CBID:280 http://www.chembase.cn/molecule-280.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(1S,2R)-2-amino-1-phenylpropan-1-ol
IUPAC Traditional name
phenylpropanolamine
Brand Name
Acutrim
Ami-Tex
Codimal
Conex
Contuss
Despec
Dexatrim
Dura-Vent
Entex
Gentab
Guaipax
Myminic
Naldecon
Nolex
Partuss
Phenoxine
Phenyldrine
Phenylfenesin
Propagest
Rhindecon
Rhymed
Snaplets
Triaminic
ULR
Vanex
Synonyms
(1S,2R)-2-Amino-1-phenyl-1-propanol
erythro-α-(1-aminoethyl)benzyl alcohol
D-(+)-Norephedrine
Phenylpropanolamine
(1S,2R)-(+)-Norephedrine
(+-)-Phenylpropanolamine
(+/-)-Norephedrin
PPA
Phenylpropanolamine
D-(+)-Norephedrine
(1S,2R)-2-氨基-1-苯基-1-丙醇
D-(+)-去甲麻黄素
苯丙醇胺
赤型-α-(1-氨基乙基)苄醇
(1S,2R)-(+)-去甲麻黄素
D-(+)-去甲麻黄素
CAS Number
14838-15-4
37577-28-9
MDL Number
MFCD00064411
Beilstein Number
2802896
PubChem SID
24886491
160963743
24859081
46508087
PubChem CID
26934

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 13.896164  H Acceptors
H Donor LogD (pH = 5.5) -2.0889428 
LogD (pH = 7.4) -1.0537072  Log P 0.8852543 
Molar Refractivity 44.9127 cm3 Polarizability 18.00672 Å3
Polar Surface Area 46.25 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 0.57  LOG S -0.87 
Solubility (Water) 2.06e+01 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Product Information Bioassay(PubChem)
Solubility
Freely soluble expand Show data source
Melting Point
51-54 °C(lit.) expand Show data source
Flash Point
113 °C expand Show data source
235.4 °F expand Show data source
Optical Rotation
[α]20/D +40.0±1°, c = 7% in 1 M HCl expand Show data source
[α]20/D +40°, c = 7 in 1 M HCl expand Show data source
Hydrophobicity(logP)
1 expand Show data source
European Hazard Symbols
Harmful Harmful (Xn) expand Show data source
MSDS Link
Download expand Show data source
Download expand Show data source
German water hazard class
3 expand Show data source
Risk Statements
22-36/37/38 expand Show data source
Safety Statements
26 expand Show data source
GHS Pictograms
GHS07 expand Show data source
GHS Signal Word
Warning expand Show data source
GHS Hazard statements
H302-H315-H319-H335 expand Show data source
GHS Precautionary statements
P261-P305 + P351 + P338 expand Show data source
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves expand Show data source
Storage Temperature
2-8°C expand Show data source
Purity
≥98.0% (NT) expand Show data source
98% expand Show data source
Grade
purum expand Show data source
Linear Formula
C6H5CH(OH)CH(CH3)NH2 expand Show data source
Empirical Formula (Hill Notation)
C9H13NO expand Show data source

DETAILS

DETAILS

DrugBank DrugBank Sigma Aldrich Sigma Aldrich
DrugBank - DB00397 external link
Item Information
Drug Groups approved; withdrawn
Description Phenylpropanolamine has been withdrawn in Canada. In November 2000, the Food and Drug Administration (FDA) issued a public health advisory against the use of the drug.
Indication For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity.
Pharmacology Phenylpropanolamine (PPA), a sympathomimetic agent structurally similar to pseudoephedrine, is used to treat nasal congestion. Phenylpropanolamine is found in appetite suppressant formulations and with guaifenesinin in cough-cold formulations. In 2000, the FDA requested that all drug companies discontinue marketing products containing phenylpropanolamine, due to an increased risk of hemorrhagic stroke in women who used phenylpropanolamine.
Toxicity May induce ventricular extrasystoles and short paroxysms of ventricular tachycardia, a sensation of fullness in the head and tingling of the extremities; LD50=1490mg/kg (orally in rat)
Affected Organisms
Humans and other mammals
Biotransformation Hepatic
Absorption Reduced bioavailability (about 38%) from gastrointestinal tract because of first pass metabolism by monoamine oxidase in the stomach and liver.
Half Life 2.1 to 3.4 hours.
External Links
Wikipedia
Drugs.com
Sigma Aldrich - 317500 external link
Packaging
10, 50 g in glass bottle

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle